Drug resistance among chronic HIV-1-infected patients naïve for use of anti-retroviral therapy in Sao Paulo city
- PMID: 17686543
- DOI: 10.1016/j.virusres.2007.06.021
Drug resistance among chronic HIV-1-infected patients naïve for use of anti-retroviral therapy in Sao Paulo city
Abstract
Primary infection with drug-resistant HIV appears to be increasing in the regions where HAART is widely available, which may reduce efficacy of first-line antiretroviral therapy. To determine prevalence of antiretroviral drug-resistant mutations in newly diagnosed subjects in a clinical setting where HAART has been widely used since 1997. One hundred and thirty-six HIV-1-infected adult patients were diagnosed with HIV infection between January 2000 and December 2006 in the HIV out-clinic at the HC/FMUSP, Sao Paulo city. These antiretroviral naïve patients were mainly referred from the blood bank, situated in the same building or elsewhere in the city. The samples were genotyped to provide HIV protease and reverse transcriptase sequence data. Major antiretroviral drug resistance mutations were classified according to Shafer et al. [Shafer, R.W., Rhee, S.Y., Pillay, D., et al., 2007. HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance. AIDS 21, 215-223]. Thirteen cases had no DNA amplification, and 123 patients were successfully analyzed, with a mean age of 37 years and 89 (72%) were males. Antiretroviral drug resistance mutations were detected in 8/123 patients (6.5%), all eight were heterosexuals and HIV asymptomatic, the mean of the CD4 cells count was 323 cells/mm(3), and the RNA plasma viral load was 4.7 log(10)/mL. We found NRTI (n=2, 1.6%), NNRTI-resistant (n=2, 1.6%) mutations, and one cases with PI mutation (0.8%). Three cases (2.4%) showed mutations for NRTI, NNRTI or PI, simultaneously. Eighty-two percent were HIV-1 B subtype, and HIV-1 F (6.5%), HIV-1 C (5.7%) and recombinant viruses (5.8%) were observed. In an unselected cohort, primary drug resistance was seen in 6.5% of the naïve for drug ART use. These results indicate that HIV drug resistance testing should be a practical approach in monitoring first-line ART. In addition, HIV-1 C seems to be emerging in Sao Paulo city.
Similar articles
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
-
[Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].Dtsch Med Wochenschr. 2007 May 4;132(18):977-82. doi: 10.1055/s-2007-979365. Dtsch Med Wochenschr. 2007. PMID: 17457780 German.
-
Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.J Med Virol. 2005 Sep;77(1):23-8. doi: 10.1002/jmv.20395. J Med Virol. 2005. PMID: 16032728
-
HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.J Clin Virol. 2009 Oct;46(2):134-9. doi: 10.1016/j.jcv.2009.07.009. Epub 2009 Aug 13. J Clin Virol. 2009. PMID: 19682948
-
[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26. Enferm Infecc Microbiol Clin. 2009. PMID: 19246124 Spanish.
Cited by
-
Structure of the HIV-1 frameshift site RNA bound to a small molecule inhibitor of viral replication.ACS Chem Biol. 2011 Aug 19;6(8):857-64. doi: 10.1021/cb200082d. Epub 2011 Jun 15. ACS Chem Biol. 2011. PMID: 21648432 Free PMC article.
-
Dynamics and features of transmission clusters of HIV-1 subtypes in the state of São Paulo, Brazil.Front Public Health. 2024 Jun 5;12:1384512. doi: 10.3389/fpubh.2024.1384512. eCollection 2024. Front Public Health. 2024. PMID: 38903572 Free PMC article.
-
BF integrase genes of HIV-1 circulating in São Paulo, Brazil, with a recurrent recombination region.PLoS One. 2012;7(4):e34324. doi: 10.1371/journal.pone.0034324. Epub 2012 Apr 2. PLoS One. 2012. PMID: 22485165 Free PMC article.
-
Characterization of HIV-1 Near Full-Length Proviral Genome Quasispecies from Patients with Undetectable Viral Load Undergoing First-Line HAART Therapy.Viruses. 2017 Dec 19;9(12):392. doi: 10.3390/v9120392. Viruses. 2017. PMID: 29257103 Free PMC article.
-
HIV genotypes and primary drug resistance among HIV-seropositive blood donors in Brazil: role of infected blood donors as sentinel populations for molecular surveillance of HIV.J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):387-92. doi: 10.1097/QAI.0b013e31828ff979. J Acquir Immune Defic Syndr. 2013. PMID: 23507660 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous